Who is rasagiline suitable for and the correct way to take it?

Rasagiline is a MAO-B inhibitor suitable for the treatment of Parkinson's disease, especially for patients with mild to moderate Parkinson's symptoms. Its applicable population mainly includes newly diagnosed early-stage Parkinson's disease patients, patients who have not yet been treated with levodopa, and patients who have already used levodopa but have a "switch phenomenon" or end-of-dose effect. Especially for patients who hope to delay the progression of symptoms and reduce the duration of levodopa use in the early stages of the disease, rasagiline is a scientific initial treatment option.

In terms of medication administration, the standard dose of rasagiline varies depending on the treatment strategy. When used as a monotherapy, the recommended dose is 1 mg per day, taken orally once; if used as a combination treatment, especially when combined with levodopa, the initial recommended dose is 0.5 mg per day, which can be adjusted to 1 mg once per day based on clinical response. Medications should be taken at the same time every day to ensure stable blood drug concentrations. There is no need to fast when taking the medication and it can be taken with food, but it is necessary to avoid consuming large amounts of tyramine-rich foods (such as aged cheese) to reduce the risk of potential hypertensive crisis.

During the use of rasagiline, patients should pay attention to drug-drug interactions. Especially when using antidepressants, ephedrine drugs, cold medicines, etc. in combination, caution is required to prevent serotonin syndrome or hypertensive reactions. Therefore, this drug must be prescribed and monitored under the guidance of a doctor.

In addition, elderly patients also need to pay attention to individualized adjustment of dosage when using it, especially when combined with other systemic diseases (such as hypertension, diabetes), a comprehensive evaluation is required. The drug should also be withdrawn gradually to prevent adverse reactions caused by sudden drug withdrawal.

Reference materials:https://www.azilect.com/